Download PDF
1 / Pages

Other users also viewed these articles

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;
10.1016/j.aohep.2024.101582
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence Ciro Celsa; Caterina Stornello; Paolo Giuffrida; Carmelo Marco Giacchetto; Mauro Grova; Gabriele Rancatore; Concetta Pitrone; Vito Di Marco; Calogero Cammà; Giuseppe Cabibbo;
Ann Hepatol. 2022;27 Supl 1:
The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophiliaHCC after HCV eradication in hemophilia Yosuke Inukai; Norihiro Imai; Kenta Yamamoto; Takanori Ito; Yoji Ishizu; Takashi Honda; Shuichi Okamoto; Takeshi Kanematsu; Nobuaki Suzuki; Tadashi Matsushita; Masatoshi Ishigami; Mitsuhiro Fujishiro;
10.1016/j.aohep.2021.100545